InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,794.71
(
-0.15%
)
Post# of 251720
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 196514

Wednesday, 11/11/2015 3:21:12 PM

Wednesday, November 11, 2015 3:21:12 PM

Post# of 251720
Cheat Sheet of Samsung Bioepis Partnerships with MRK/BIIB

Humira FoB
Partnered with BIIB in EU, Switzerland, Russia, Turkey; partnered with MRK in RoW (including US).

Enbrel FoB
Partnered with BIIB in EU, Switzerland, Japan; partnered with MRK in RoW excluding US. (Samsung has no Enbrel FoB program in US due to AMGN’s long-lasting US patent protection.)

Remicade FoB
Same breakdown of countries as Humira FoB.

Herceptin FoB
Partnered with MRK worldwide.

Lantus FoB
Partnered with MRK worldwide.

Source:
http://www.biosimilarnews.com/positive-phase-iii-outcomes-from-samsung-bioepis-biosimilar-candidates

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up